This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Biofermin Pharmaceutical Co., Ltd., Yokohama City University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Tomohiro Kawahara: Innovator in Fat-Associated Disease Treatment
Introduction
Tomohiro Kawahara is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of fat-associated diseases and inflammation. His innovative approach has led to the development of a unique agent that addresses these health concerns.
Latest Patents
Kawahara holds a patent for an "Agent for preventing or treating fat-associated diseases and/or inflammation." The objective of this invention is to provide an effective solution for preventing or treating fat-associated diseases and inflammation. The agent comprises a bacterium or a processed product thereof, showcasing Kawahara's innovative approach to tackling these health issues.
Career Highlights
Throughout his career, Tomohiro Kawahara has worked with reputable organizations, including Biofermin Pharmaceutical Co., Ltd. and Public University Corporation Yokohama City University. His experience in these institutions has allowed him to further his research and development in the medical field.
Collaborations
Kawahara has collaborated with esteemed colleagues such as Yoshiki Tanaka and Masaki Shimakawa. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Tomohiro Kawahara's innovative work in the treatment of fat-associated diseases and inflammation highlights his significant contributions to medical science. His patent and collaborations reflect his dedication to improving health outcomes through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile